Evidence map›Paper›PMID 36207091›Full record

ArticleArtificial intelligence in medicine2022

Mathematical modeling and AI based decision making for COVID-19 suspects backed by novel distance and similarity measures on plithogenic hypersoft sets.

Muhammad Rayees Ahmad, Usman Afzal

Abstract read
In one paragraph

Article in Artificial intelligence in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Muhammad Rayees AhmadDepartment of Mathematics, University of Management and Technology, Lahore 54770, Pakistan.
Usman AfzalDepartment of Mathematics, University of Management and Technology, Lahore 54770, Pakistan. Electronic address: usman.afzal@umt.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It goes without saying that coronavirus (COVID-19) is an infectious disease and many countries are coping with its different variants. Owing to the limited medical facilities, vaccine and medical experts, need of the hour is to intelligently tackle its spread by making artificial intelligence (AI) based smart decisions for COVID-19 suspects who develop different symptoms and they are kept under observation and monitored to see the severity of the symptoms. The target of this study is to analyze COVID-19 suspects data and detect whether a suspect is a COVID-19 patient or not, and if yes, then to what extent, so that a suitable decision can be made. The decision can be categorized such that an infected person can be isolated or quarantined at home or at a facilitation center or the person can be sent to the hospital for the treatment. This target is achieved by designing a mathematical model of COVID-19 suspects in the form of a multi-criteria decision making (MCDM) model and a novel AI based technique is devised and implemented with the help of newly developed plithogenic distance and similarity measures in fuzzy environment. All findings are depicted graphically for a clear understanding and to provide an insight of the necessity and effectiveness of the proposed method. The concept and results of the proposed technique make it suitable for implementation in machine learning, deep learning, pattern recognition etc.

Indexed as

COVID-19VaccinesArtificial IntelligenceDecision MakingHumansModels, TheoreticalVaccinesCOVID-19Multi-criteria decision making (MCDM)Plithogenic distance measure (PDM)Plithogenic hypersoft set (PHSS)Plithogenic similarity measure (PSM)

Identifiers

PMID36207091
PMCPMC9436789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.